Jasper Therapeutics, Inc. (JSPRW) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$75.80M | -6.4% |
| 2024 | -$71.27M | -10.6% |
| 2023 | -$64.47M | -71.1% |
| 2022 | -$37.69M | -23.0% |
| 2021 | -$30.64M | +3.3% |
| 2020 | -$31.67M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$75.80M | -6.4% |
| 2024 | -$71.27M | -10.6% |
| 2023 | -$64.47M | -71.1% |
| 2022 | -$37.69M | -23.0% |
| 2021 | -$30.64M | +3.3% |
| 2020 | -$31.67M | — |